Prosecution Insights
Last updated: May 29, 2026

Dewitt LLP (Madison)

23 pending office actions • 23 clients • 23 examiners • 21 art units • 0 of 23 (0%) have an AI response strategy ready • 67 patents granted in the last 365 days

Portfolio Summary

23
Total Pending OAs
13
Non-Final OAs
8
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 23 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

14
Overdue
1
Due this week
2
Due this month
2
Due in next 60 days
4
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 23 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (14)Due ≤ 7 days (1)Due ≤ 30 days (2)Due ≤ 60 days (2)Due later (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
18
Medium (78%)
2
Easy (9%)
3
Unknown (13%)

Rejection Statute Mix

BucketCases
§103 only13 (57%)
§102 only3 (13%)
§112 only2 (9%)
Double-patenting + other2 (9%)
No statute on record3 (13%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

16
Life Sciences
70% of docket
1
Information Tech
4% of docket
1
Communications
4% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
22% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

230 h
Manual time on pending OAs
46 h
Time saved (low, 20%)
80 h
Time saved (mid, 35%)
2.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HIBSHMAN, SARAH GRACE 1 40.9% +46.3%
LEWIS, JUSTIN V 1 55.1% +17.6%
MENON, KRISHNAN S 1 59.8% +11.8%
ARMSTRONG, SUSANNAH SIPPLE 1 40.0% +48.5%
TAWFIK, SAMEH 1 63.0% +30.9%
BURKE, THOMAS P 1 43.2% +22.3%
BLUMEL, BENJAMIN P 1 70.7% +30.6%
UNDERDAHL, THANE E 1 59.0% +50.0%
PHAM, QUAN L 1 69.9% +28.9%
KRISHNAN, GANAPATHY 1 52.2% +0.0%

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19237691 FLAVONOID-CONTAINING COMPOSITIONS AND TREATMENT OF VIRAL DISEASES WITH SAME HIBSHMAN, SARAH GRACE 43d overdue
18827214 TWO-PIECE, FLAT-PACKING, QUICK-DEPLOYING POINT-OF-PURCHASE DISPLAY LEWIS, JUSTIN V 29d overdue
18403028 SITE-SPECIFIC ANTIBODY-DRUG GLYCONJUGATES AND METHODS BLUMEL, BENJAMIN P 28d overdue
18533548 IMAGING SENSOR ASSEMBLY PHAM, QUAN L 8d overdue
18637243 COMPOSITIONS TO CONTROL THE RELEASE RATES OF CHEMICAL PESTICIDES ARMSTRONG, SUSANNAH SIPPLE 1d overdue
18579119 CLOSURE CAP AND CLOSURE SYSTEM FOR A SYRINGE THAT IS PREFILLED WITH A MEDICAMENT OR MEDICAL ACTIVE SUBSTANCE BURKE, THOMAS P 23d
18683433 METHOD AND TUBULAR BAG MACHINE FOR THE CONTINUOUS PRODUCTION OF BLOCK-BOTTOM BAGS TAWFIK, SAMEH 70d
18536601 FEED SUPPLEMENT BOLUS WITH ACTIVE YEAST UNDERDAHL, THANE E 70d

Client Portfolio (23 clients)

Top Art Units

Art UnitApps
16522
16582
16231
36371
17771
16161
37311
37411
16711
16991

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19237691 FLAVONOID-CONTAINING COMPOSITIONS AND TREATMENT OF VIRAL DISEASES WITH SAME Amh Biotech LLC HIBSHMAN, SARAH GRACE 1623 §103 Non-Final OA 43d overdue Pending Jun 13, 2025
18827214 TWO-PIECE, FLAT-PACKING, QUICK-DEPLOYING POINT-OF-PURCHASE DISPLAY Great Northern Corporation LEWIS, JUSTIN V 3637 §103 Non-Final OA 29d overdue Pending Sep 06, 2024
18666032 METHODS FOR REDUCING IMPURITIES IN SILK FIBROIN PREPARATIONS Cocoon Biotech Inc. MENON, KRISHNAN S 1777 DPOther Non-Final OA 71d Pending May 16, 2024
18637243 COMPOSITIONS TO CONTROL THE RELEASE RATES OF CHEMICAL PESTICIDES Envionics LLC ARMSTRONG, SUSANNAH SIPPLE 1616 Other Final Rejection 1d overdue Pending Apr 16, 2024
18683433 METHOD AND TUBULAR BAG MACHINE FOR THE CONTINUOUS PRODUCTION OF BLOCK-BOTTOM BAGS Rovema GmbH TAWFIK, SAMEH 3731 §103 Final Rejection 70d Pending Feb 13, 2024
18579119 CLOSURE CAP AND CLOSURE SYSTEM FOR A SYRINGE THAT IS PREFILLED WITH A MEDICAMENT OR MEDICAL ACTIVE SUBSTANCE Inductio AG BURKE, THOMAS P 3741 §103 Non-Final OA 23d Pending Jan 12, 2024
18403028 SITE-SPECIFIC ANTIBODY-DRUG GLYCONJUGATES AND METHODS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. BLUMEL, BENJAMIN P 1671 §112 Final Rejection 28d overdue Pending Jan 03, 2024
18536601 FEED SUPPLEMENT BOLUS WITH ACTIVE YEAST Techmix, LLC UNDERDAHL, THANE E 1699 DPOther Non-Final OA 70d Pending Dec 12, 2023
18533548 IMAGING SENSOR ASSEMBLY Maranon, Inc. PHAM, QUAN L 2637 §102 Final Rejection 8d overdue Pending Dec 08, 2023
18560536 ORAL SOLUTION BASED ON CITICOLINE AND NICOTINAMIDE FOR USE IN THE TREATMENT OF GLAUCOMA Omikron Italia S.r.l. KRISHNAN, GANAPATHY 1693 Other Non-Final OA 2d overdue Pending Nov 13, 2023
18558834 A METHOD FOR REFINING MACROALGAE Origin By Ocean DIVIESTI, KARLA ISOBEL 1792 §103 Non-Final OA 83d Pending Nov 03, 2023
18386372 ROLLED MATERIAL OR SCREEN MESH DISPENSER Erdman Automation Corporation DIAS, RAVEEN J 3654 §112 Final Rejection 7d Pending Nov 02, 2023
18470587 ADMINISTRATION REGIMENS FOR MICRONEEDLE PATCH DEVICES FOR DELIVERY OF IMMUNOGENIC COMPOSITIONS Georgia Tech Research Corporation SMALE, AVERY E 3783 §103 Non-Final OA 42d Pending Sep 20, 2023
18469664 SITE-SPECIFIC CLEAVAGE AND ELIMINATION OF DNA IN BACTERIAL SPECIES WITH SEGMENTED CHROMOSOMES The Board Of Trustees Of The Leland Stanford Junior University Leland Stanford Junior University Jun MOAZZAMI, NAGHMEH NINA 1652 §103 Non-Final OA 32d overdue Pending Sep 19, 2023
18260672 SYNTHESIS PROCESS Xellia Pharmaceuticals Aps BANERJEE, KOYELI 1658 §103 Non-Final OA 20d Pending Jul 07, 2023
18246250 STERILE ORGANISMS, METHODS OF MAKING, AND METHODS OF USE THEREOF BRANDEIS UNIVERSITY RAHMAN, MASUDUR 1633 §103 Non-Final OA 49d overdue Pending Mar 22, 2023
18041357 NEW ANTIMICROBIAL PEPTIDES Università Cattolica del Sacro Cuore REYNOLDS, FRED H 1658 §102 Non-Final OA 46d overdue Pending Feb 10, 2023
17993450 BACKGROUND REDUCTION METHOD FOR SOIL XRF SPECTRUM BASED ON XRF-EGAN MODEL Yangtze Delta Region Institute (Huzhou), University Of Electronic Science And Technology Of China NGUYEN, MAIKHANH 2144 §102 Non-Final OA 57d Pending Nov 23, 2022
17997003 NEW COUMARIN-POLYMER CONJUGATES AND USES THEREOF Onyel Biotech S.r.l. STEINKE, SEAN JAMES 1619 §103 Final Rejection 113d overdue Pending Oct 24, 2022
17912770 ATP-DEPENDENT DNA LIGASE Arcticzymes AS HUTSON, RICHARD G 1652 §103 Final Rejection 80d overdue Pending Sep 19, 2022
17882806 FUNCTIONALIZED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM Silatronix, Inc. PILLAY, DEVINA 1726 §103 Non-Final OA 49d overdue Pending Aug 08, 2022
17607695 COMPOSITION AND METHOD FOR CRYOPRESERVATION OF CELLS Regents Of The University Of Minnesota MOSS, NATALIE M 1653 Other Final Rejection 50d overdue Pending Oct 29, 2021
17124530 Fish feed and method for smoltification and prevention of desmoltification in Salmonidae, and for prophylaxis and treatment of haemorrhagic smolt syndrome (HSS) in Salmonidae Stim. AS MCCLAIN, TYNESHA L. 1793 §103 Non-Final OA 43d overdue Pending Dec 17, 2020

Managing Dewitt LLP (Madison)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month